Response:
1) Company being overseas is why they're so far ahead on research and development. Remember, Marijuana has been illegal up until recently in the United States. They're based out of Israel, where their Government welcomes and encourages the research. They have guidelines to follow in order to utilize the biggest hospitals in Israel for research studies. Not like they're operating out of a 3rd world country without experienced, accredited Doctors.
2) Yeah, they're at $0.69 right now. They have a fair share structure compared to other MMJ stocks that have run high without revenue/profit. There's certainly risk in everything, but if you read through the DD -- there's a lot more potential for REWARD here than 99% of "pennystocks". This is also OTC QB vs. OTC Pink Sheets -- so that's an upgrade as well.
3) If the research fails? Thankfully the 8K's have all indicated success so far. Their IRB approval was big and they moved forward to studies at the largest hospital in Israel, where an 8K announced "encouraging results" which lead to increasing the size and scope of the study. Then they add two Advisor Board Members -- one who specializes in FDA approvals and one who has been a Dermatologist for 15+ years. I think that all points to POSITIVE updates coming.
4) Skin Cream is the ONLY product going for them? You must have missed the memo about the Sublingual Soluble Tablet... The product that will be able to treat PTSD, Fibromyalgia, Migraines, etc. What about the Multiple Myeloma product that in early studies/testing has yielded good results so far on mice? Yeah, early stages, but those updates were last year too. Psoriasis isn't a tiny market. AstraZeneca sold off their TROUBLED drug, which was linked to SUICIDE as a side effect, for $445 MILLION... So, when OWCP releases a Natural Cannabis-based product that doesn't make you want to kill yourself... Tell me why that product can't have a value that exceeds $500M -- to be Conservative.
